YHB Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302K | Hold |
575
| – | – | 0.02% | 254 |
|
|
2025
Q1 | $365K | Sell |
575
-2
| -0.3% | -$1.27K | 0.03% | 225 |
|
|
2024
Q4 | $411K | Hold |
577
| – | – | 0.03% | 210 |
|
|
2024
Q3 | $607K | Hold |
577
| – | – | 0.05% | 189 |
|
|
2024
Q2 | $606K | Hold |
577
| – | – | 0.05% | 183 |
|
|
2024
Q1 | $555K | Sell |
577
-56
| -9% | -$53.9K | 0.05% | 186 |
|
|
2023
Q4 | $556K | Sell |
633
-12
| -2% | -$10.5K | 0.05% | 181 |
|
|
2023
Q3 | $531K | Sell |
645
-25
| -4% | -$20.6K | 0.05% | 185 |
|
|
2023
Q2 | $481K | Sell |
670
-37
| -5% | -$26.6K | 0.04% | 193 |
|
|
2023
Q1 | $581K | Sell |
707
-72
| -9% | -$59.2K | 0.06% | 178 |
|
|
2022
Q4 | $562K | Sell |
779
-14
| -2% | -$10.1K | 0.06% | 173 |
|
|
2022
Q3 | $546K | Hold |
793
| – | – | 0.06% | 182 |
|
|
2022
Q2 | $469K | Sell |
793
-10
| -1% | -$5.91K | 0.05% | 190 |
|
|
2022
Q1 | $561K | Hold |
803
| – | – | 0.05% | 190 |
|
|
2021
Q4 | $507K | Hold |
803
| – | – | 0.04% | 210 |
|
|
2021
Q3 | $486K | Hold |
803
| – | – | 0.04% | 202 |
|
|
2021
Q2 | $449K | Hold |
803
| – | – | 0.04% | 206 |
|
|
2021
Q1 | $404K | Sell |
803
-10
| -1% | -$5.03K | 0.04% | 213 |
|
|
2020
Q4 | $393K | Buy |
813
+3
| +0.4% | +$1.45K | 0.04% | 208 |
|
|
2020
Q3 | $453K | Sell |
810
-100
| -11% | -$55.9K | 0.05% | 195 |
|
|
2020
Q2 | $568K | Hold |
910
| – | – | 0.08% | 127 |
|
|
2020
Q1 | $444K | Buy |
910
+10
| +1% | +$4.88K | 0.08% | 125 |
|
|
2019
Q4 | $338K | Sell |
900
-800
| -47% | -$300K | 0.05% | 147 |
|
|
2019
Q3 | $472K | Buy |
+1,700
| New | +$472K | 0.07% | 134 |
|